North America Microtome Market Growth and Recent Trends by 2027

The North America microtome market is expected to reach US$ 94,198.6 thousand in 2027 from US$ 59,961.2 thousand in 2019. The market is estimated to grow with a CAGR of 6.0% from 2020-2027.

Cancer is one of the significant causes of death across the globe, and its increasing prevalence is boosting the number of histopathology tests. A tissue pathology analysis is needed for the examination of a malignant tumour to predict the onset of cancer. According to data reported in the American Cancer Society, expected 1,762,450 cancers were diagnosed in 2019, which comprises more than 4,800 new cases per day in the US. Moreover, 103,250 cancer deaths were recorded among the older group in 2019, accounting for 17% of all cancer deaths in the country. Increasing rates of cancer and growing knowledge concerning early diagnostic procedures are expected to boost the adoption rate of microtomes throughout the forecast period. Examination of biopsy tissues helps pathologists in discovering cancer type, stage, and the degree of disease spread.

Moreover, increasing awareness programs initiated by organizations such as World Health Organization (WHO), National Cervical Cancer Coalition, and the Centers for Disease Control and Prevention (CDC) for cancer screening are further driving the market growth. For example, the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) of CDC have granted uninsured, low-income, and underserved women access to appropriate breast and cervical cancer screening and diagnostic services. The factors mentioned above are expected to drive the growth of the market for microtome during the coming years.

Furthermore, the impact of the COVID-19 pandemic on cancer patients, surgical cases, and others is high in terms of the maintenance of surgical wounds. The companies in the microtome and its associated accessories market are facing issues in keeping their production facilities fully functional due to a shortage of staff and resources amidst the COVID-19 outbreak. Drug discovery and manufacturing is the most crucial part of the development of new therapeutics. Since the surge of COVID-19 cases, the pharmaceutical industry is facing a decrease in production capabilities. Although all regular surgeries in countries with COVID-19 disease have been halted during the pandemic era, the requirement for coordinated emergency care delivered by teams with appropriate personal protective equipment takes precedence.

North America Microtome Market Revenue and Forecast to 2027 (US$ Mn)

North America Microtome Market– Market Segmentation

By Product

• Microtome Instruments
  • Rotary Microtomes
  • Cryostat Microtomes
  • Vibrating Microtomes
  • Other Microtome Instruments
• Microtome Accessories

By Technology

• Manual Microtomes
• Semi-automated Microtomes
• Fully Automated Microtomes

By End User

• Hospitals
• Clinical Laboratories
• Other End Users

By Country

• US
• Canada
• Mexico

Company Profiles

• PHC Holdings Corporation
• MEDITE Medical GmbH
• Sakura Finetek USA, Inc.
• Leica Biosystems Nussloch GmbH (Danaher)
• Boeckeler Instruments, Inc.

North America Microtome Report Scope